APG2575

· Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APG2575, covering 2025-04-16 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Global Trial in APG2575 for Patients With CLL/SLL [Phase 3]